Hepa 1-6 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF2412
Target Cell Organism: Mouse
Target Cell Alternative Name: Hepa1-6
Target Cell Name: Hepa 1-6
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide Hepa 1-6-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Hepa 1-6
Target Cell Organism
Mouse
Target Cell Background
The Hepa 1-6 tumorigenic epithelial cell line is derived from liver cells of the BW7756 mouse (Mus musculus) with hepatoma. Hepa 1-6 has been negatively tested for mousepox and is widely used in mammalian liver tissue functions research.
Target Cell Alternative Name
Hepa1-6
Related Diseases
Liver Hepatoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
Hepa 1-6-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry